MedTrace Logo

Ointment to Prevent Scar After Thyroidectomy

NCT05838833 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2023-05-03

No results posted yet for this study

Summary

The goal of this study is to evaluate the efficacy and Safety of INV-001 administration for the prevention of scar after thyroidectomy.

Participants will be asked to apply ointment on their scar for 12 weeks.

Conditions

  • Scar

Interventions

DRUG

INV-001

Patient will be assigned to one of three arms.

Sponsors & Collaborators

  • Innovo Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Minjeong Kim, Master · New Drug development Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-14
Primary Completion
2023-12-31
Completion
2024-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05838833 on ClinicalTrials.gov